Imexpharm (STC:IMP) Construction In Progress: ₫343,060 Mil (As of Mar. 2026)


STC:IMP Imexpharm Corp STC:IMP
98 GF Score
Price ₫42,900.00
GF Value ₫51,706.57
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Imexpharm Construction In Progress?

Imexpharm STC:IMP -1.38% 98 Construction In Progress is ₫343,060 Mil as of Mar. 2026. GuruFocus rates STC:IMP with a GF Score™ of 98/100 and a GF Value™ of ₫51,706.57 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Imexpharm's quarterly construction in progress increased from Sep. 2025 (₫335,557 Mil) to Dec. 2025 (₫338,600 Mil) and increased from Dec. 2025 (₫338,600 Mil) to Mar. 2026 (₫343,060 Mil).

Imexpharm's annual construction in progress increased from Dec. 2023 (₫71,308 Mil) to Dec. 2024 (₫71,397 Mil) and increased from Dec. 2024 (₫71,397 Mil) to Dec. 2025 (₫338,600 Mil).

Imexpharm Construction In Progress Historical Data

* Premium members only.

The historical data trend for Imexpharm's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imexpharm Construction In Progress Chart

Imexpharm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 519,462.65 597,083.38 71,307.85 71,397.31 338,599.99

Imexpharm Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66,473.96 329,789.29 335,556.80 338,599.99 343,059.51
STC:IMP
98GF Score
Imexpharm Corp STC:IMP
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imexpharm Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₫343,060 Mil mean?
Imexpharm (STC:IMP) has a Construction In Progress of ₫343,060 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Imexpharm and its competitors.
Is Imexpharm's Construction In Progress too high?
Imexpharm's current Construction In Progress is ₫343,060 Mil. Overall, Imexpharm has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Imexpharm's Construction In Progress compare to ZTS?
Imexpharm's Construction In Progress of ₫343,060 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Imexpharm and its competitors. Imexpharm's current Construction In Progress is ₫343,060 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imexpharm stock overvalued right now?
Based on GuruFocus' analysis, Imexpharm (STC:IMP) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫51,706.57, compared to a current price of ₫42,900.00 — trading 17% below its estimated fair value. The current Construction In Progress is ₫343,060 Mil. Imexpharm's overall GF Score™ is 98/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Imexpharm (STC:IMP), the current Construction In Progress is ₫343,060 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imexpharm (STC:IMP) Overvalued in 2026?

Based on GuruFocus' analysis, Imexpharm stock appears to be undervalued. The current stock price of ₫42,900.00 is trading 17% below its estimated GF Value™ of ₫51,706.57. GuruFocus considers Imexpharm to be Modestly Undervalued.

Key valuation signals for STC:IMP:

  • Construction In Progress: ₫343,060 Mil
  • GF Value™: ₫51,706.57 vs. price of ₫42,900.00 (17% below fair value)
  • GF Score™: 98/100 with 2 warning signs

No single metric tells the full story. See the STC:IMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Imexpharm Business Description

Address 4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. The company's products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.
98GF Score

Get the complete analysis for STC:IMP

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫42,900.00
Price
₫51,706.57
GF Value